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Purpose/Objective: In radiotherapy, the total treatment 
dose is usually not given in one single fraction but in a 
fractionated fashion over a period of four to seven weeks. 
Between these so-called treatment fractions, differences in 
the location of relevant organs and the tumor with respect to 
the treatment isocenter are referred to as inter-fractional 
set-up errors. The purpose of this work is to determine the 
inter-fractional set-up error, for prostate patients, using a 
kilovoltage Cone Beam CT (CBCT) and a robotic hexapod 
treatment couch for accurate patient positioning in six 
degrees of freedom (DOF). 
Materials and Methods: 15 prostate cancer patients were 
treated with radical rotational radiotherapy (VMAT). The 
robotic couch corrected the misalignments in all 6-DOF and a 
pre-treatment verification CBCT was then obtained. A total 
of 425 fractions were evaluated. For each patient the set-up 
corrections of the three principal axes (L/R, A/P, and C/C) 
and three rotational movements (pitch, roll, and yaw) were 
extracted from the CBCT software. 
The following parameters were calculated: 
 For the complete data set (15 patients, 425 
fractions) a global mean (the systematic error, M) 
and standard deviation (σ) of the set-up corrections 
for each direction. 
 For each individual patient the means of the set-up 
corrections for each direction, and the standard 
deviation (Σ) of these means. 
Also, a Principal Components Analysis (PCA) on the 
correlation matrix was performed to determine the principal 
components. 
Results: Table 1 shows the results of the parameters 
mentioned before. 
Figure 1 shows a histogram for the three rotations. 
The eigenvalues from the PCA are: λ1= 0.295, λ2=0.257, 
λ3=0.163, λ4=0.114, λ5=0.104, λ6=0.068. 
 
 
Conclusions: The results shown in the Table 1 suggest that 
the biggest systematic error is found in the Yaw direction, 
with the smallest standard deviation compared with the 
other angles. Otherwise the standard deviation on the pitch 
seems to be significantly higher compared with the other 
angles. That suggests that the biggest source of error in the 
set up is, in fact, in that direction. The PCA results suggest 
that it is not possible to make any significant reduction in the 
complexity of the data as the most significant component 
only explains 30% of the variance. Despite the fact that the 
robotic couch only allows rotations in the [-3, 3] degree 
interval, we found out that the 5% of the corrections were 
larger than 3 degrees in the pitch direction. 
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Purpose/Objective: The aim of this study was to evaluate 
the effective potentiality of TomoEDGE dynamic jaw (DJ) 
with small/large field width (FW) compared to the regular 
fixed helical tomotherapy in the treatment of prostate 
cancer. 
Materials and Methods: Two clinical situations were chosen 
for comparison between fix jaw (FJ) mode with FW of 2.5 cm 
and DJ delivery with a FW of 2.5cm (DJ_1) and 5.0 cm 
(DJ_2): prophylactic whole pelvis (WP) and small-field 
irradiation to the prostate and seminal vesicles (P) only. 
Pitch of 0.287 and modulation factor of 2.5 were used in all 
simulated plans. For WP plans, hypofractionated (51.8, 61.6, 
65.5, 65.5, 74.2Gy-28 fr) simultaneous integrated boost was 
prescribed to pelvic lymphnodes, most cranial and the first 
third of seminal vesicles, overlap between rectum and 
prostate, prostate respectively. For P plans, no pelvis 
irradiation, keeping the same prescribed doses in WP 
scenario for the other 4 planning target volumes (PTVs). 
Six patients were selected for planning comparisons. For each 
patient, WP and P plans were simulated for the three 
different settings. For each clinical scenario the same 
contours, prescriptions and planning objectives were 
manteined. Plan quality was evaluated in terms of coverage, 
conformity index (CI) and homogeneity index (HI) of the 
prescribed dose to the PTV, maximum/minimum, mean doses 
and dose-volume histograms (DVH) data for organs at risk 
(OARs) and delivery time. 
Results: Concerning target coverage, the use of DJ 
determined a slightly reduced dose homogeneity in the PTVs 
for both clinical scenarios. CI showed no significant 
differences for the three sets in the two clinical scenarios. 
Furthermore, worst results for DJ_2 (two paired t-test; 
p<0.05) were obtained by analyzing the overall mean V98% 
values for PTVs coverage (89%, 88% and 80% for FJ, DJ_1 and 
DJ_2) in the WP plans. Better results was obtained for P plans 
(88%, 87% and 85% for FJ, DJ_1 and DJ_2). With regard to 
OARs, a significant dose sparing of penile bulb was observed 
for WP and P scenarios when DJ was used (mean dose 
difference up to 12 Gy). In the WP cases, no significant 
increase in the other OARs exposure was detected when FJ 
was compared with DJ_1, as most of OARs are generally 
located within the irradiated area. The larger FW determined 
a sligtly reduced sparing of most OARs (Fig 1). A significant 
reduction in delivery duration of 60% on average could be 
accomplished for WP and P irradiations with DJ_2. 
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Conclusions: The use of DJ reduced irradiation of OARs 
positioned in the cranio-caudal border of PTVs. The sparing 
was significant for a small organ (penile bulb) but limited to 
low-dose DVH region for the others. A larger field width (5.0 
vs. 2.5 cm) has led to a significant reduction of delivery time, 
a slightly reduced dose homogeneity in the PTVs, a quite 
similar OARs sparing when only prostate and seminal vesicles 
were treated. A lower sparing for all OARs resulted for WP 
plans DJ_2, but differences were in the range 1.4-2.9 Gy. 
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Purpose/Objective: Pre-treatment verification of Volumetric 
Modulated Arc Therapy (VMAT) is a common practice. MLC 
trajectory records analysis has been suggested as a method 
to appropriately control modulated beam delivery day-to-
day. These trajectory logs consist in a binary file generated 
on a TrueBeam (Varian Medical Systems), containing the 
position expected and actual of many machine parameters, 
such as gantry angle, jaws and leaves positions and fraction 
of overall treatment delivered. These data are collected and 
saved every 20 ms. 
This study analyses the effect of day-to-day MLC position on 
the final dose distribution based on the trajectory log files. 
Materials and Methods: 10 VMAT plans (4 head and neck and 
6 prostates) irradiated with 6MV on a TrueBeam were 
selected. For each plan, trajectory logs for all fractions 
(ranging from 23 to 35) were analyzed and two trajectory 
logs were selected. First the trajectory log with maximum 
root mean square (RMS) of the difference on the position of a 
leave between expected and real position along the fraction 
(from now PosMax) and second, the trajectory log with 
maximum RMS of the difference between expected and real 
gap generated by opposed leaves (GapMax). Using MATLAB (v 
7.12), two new plans were created with the MLC positions, 
gantry angle, and Monitor Units delivered in each control 
point, recorded on PosMax and GapMax files and new dose 
distributions were calculated and compared with the original 
by using Eclipse V.13 (Varian Medical Systems) treatment 
planning system (TPS).  
Results: On table 1 is presented the maximum dose 
difference between plans generated by using the 'PosMax' and 
'GapMax' trajectory logs and the original plan (set as a 
reference). For all dose distributions maximum differences 
were found on the external part of the body. Differences on 
PTV doses were smaller than 2% of the prescribed dose in all 
treatments studied. In all prostate cases dose differences 
were higher on healthy tissue than on PTV, that was not 
observed on the head and neck cases. 
 
Conclusions: Assuming we can rely on trajectory logs as a 
treatment actual delivery (what has to be assured 
independently) no meaningful differences were found 
between planned and delivered dose distributions, although 
the worst scenario was considered. Similar differences were 
found independently of using PosMax or GapMax log files to 
recalculate the dose distributions. Although in all cases 
studied organs at risk met the dosimetric constraints, further 
investigations could be needed to study the actual delivered 
dose in normal tissue. The software developed generates a 
plan with the applied treatment parameters and can 
contribute to a better estimation of the delivered dose on 
the patient. Next stage in our studies will be the calculation 
of these plans on the CBCT images recorded during the 
treatment. 
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